Red List
VREX
Varex Imaging Corporation
Healthcare · Medical Devices · small-cap ($462M)
-31.2%
from rolling 252-day high of $14.56 set 2026-01-22 · 112d ago
Current
$10.02
Decline depth
-31.2%
Decline σ
4.7σ
TFC
3/5 bearish
Rolling 252-day high Up day Down day Last 90 trading days · data from Alpaca

Structural break signals

VREX qualifies for the Red List on decline depth.

Decline depth
-31.2%
From rolling 252-day high of $14.56, 112d ago. Past the 30% Amber threshold.
Time-frame continuity
3/5 bearish
Latest bar across daily/weekly/monthly/quarterly/yearly time frames. A bar counts as bearish when it's a 2-Down or a red 3. Past the 3/5 Watch threshold.
Decline sigma
4.7σ
Drop from local high over the last 20 bars, expressed in units of the stock's typical daily volatility (5.03% per day). Past the ≥4σ Watch threshold.

The structural read

What price action says about VREX.

VREX qualifies for the Red List on decline depth — down -31.2% from its rolling 252-day high. Past 30% with the high set inside the last four months — the recency clause that often precedes further breakdown. Depth plus recency: this is the pattern many investors call a falling knife.

Cross-confirmation: also showing 3/5 bearish time frames.

Cross-confirmation: decline sigma also reads 4.7σ over 20 bars.

Earnings on file: 2026-05-07. Tiering is unaffected by earnings dates — listings reflect price structure only.

52-week range

52W low $6.76 41.8% of range 52W high $14.56

Sector context · Healthcare

182 other Healthcare tickers are on Broken Stocks.

92 Red List
43 Amber
47 Watch
-35.8% Median decline

Worst in sector: OPRX (-76.7%). Least-bad: ANIP (-20.0%). See all Healthcare listings →

Questions about VREX

What people ask.

Why is VREX on Broken Stocks?

VREX qualifies for the Red List on decline depth. It is down -31.2% from its rolling 252-day high of $14.56, set on 2026-01-22 — 112d ago.

Is VREX a falling knife?

By the most common technical definition — a steep, recent breakdown from a fresh high — yes. VREX is down -31.2% from its 52-week high of $14.56, set 112d ago. That combination of depth (past the 30% Amber threshold) and recency (high set inside the last 120 days) is the textbook falling-knife pattern. Whether to try to catch it is a separate question — historically most attempts to bottom-pick continue lower before reversing. Broken Stocks flags the pattern; it does not recommend buying or selling.

Is VREX a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is VREX trading inside its 52-week range?

At $10.02, VREX sits 41.8% of the way from its 52-week low ($6.76) to its 52-week high ($14.56). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has VREX been declining?

The current 31.2% decline accrued over 112d, which annualizes to roughly -101.7% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does VREX compare to its sector?

There are 182 other Healthcare tickers on Broken Stocks: 92 Red, 43 Amber, 47 Watch, with 55 showing recovering structural signals. Median sector decline is -35.8% — VREX's decline is shallower than the sector median.

Does VREX's earnings date affect its tier?

No. Tiering is decided purely by decline depth and recency of the rolling-high date. The earnings date on file (2026-05-07) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.